INM — Inventionmed SA Income Statement
0.000.00%
Last trade - 00:00
- PLN41.06m
- PLN41.06m
- PLN0.00m
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | PRESS | ARS | ARS | PRESS |
Standards: | — | — | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.041 | 0.005 | 0.01 | 0.004 | 0.001 |
Cost of Revenue | |||||
Gross Profit | 0.007 | -0.029 | 0.005 | -0.002 | -0.01 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.927 | 0.553 | 0.684 | 0.698 | 1.63 |
Operating Profit | -0.886 | -0.548 | -0.674 | -0.694 | -1.63 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.757 | -0.401 | -0.674 | -22.2 | -2.46 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.77 | -0.428 | -0.674 | -22.2 | -2.46 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.77 | -0.428 | -0.674 | -22.2 | -2.46 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.736 | -0.453 | -0.674 | -22.2 | -2.46 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | -0.002 | -0.003 | -0.11 | -0.013 |
Dividends per Share |